MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
申请人:Vertex Pharmaceuticals Incorporated
公开号:EP2970353A2
公开(公告)日:2016-01-20
US20140274930A1
申请人:——
公开号:US20140274930A1
公开(公告)日:2014-09-18
US9890176B2
申请人:——
公开号:US9890176B2
公开(公告)日:2018-02-13
[EN] MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS<br/>[FR] DÉRIVÉS DU MANNOSE POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
申请人:VERTEX PHARMA
公开号:WO2014165107A2
公开(公告)日:2014-10-09
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I) The invention also provides processes for making the compounds described herein. Furthermore, the present invention provides a composition comprising the compounds described herein, and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The present invention also provides methods of treating or preventing bacteria infection in a subject, comprising administering to the subject an effective amount of the compound or the composition described herein.
Lead tetraacetate mediated one pot oxidative cleavage and acetylation reaction: an approach to apio and homologated apio pyrimidine nucleosides and their anticancer activity
作者:Amarendra Panda、Sehbanul Islam、Manas Kumar Santra、Shantanu Pal
DOI:10.1039/c5ra19080k
日期:——
efficient and versatile strategy of general applicability towards apio and homologated apio pyrimidines has been delineated. The methodology shows tosylation followed by in situ cyclization and one pot oxidative cleavage and acetylation by Pb(OAc)4 as the key steps. The methodology has been applied to D-ribose and D-mannose derivatives to achieve asymmetric synthesis of apio and homologated apio pyrimidine